Media
Femasys in the
Femasys in the
conversation.
Podcasts, press coverage, educational videos, webinars, blog posts, and press resources — everything you need to stay current on Femasys and our women’s health innovations.
Featured
News
August 2026
Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million
Oct 6, 2022
Femasys Inc. Announces Enrollment Completion for Stage 2 Study of FemBloc for Permanent Birth Control
GlobeNewswire
Read ↗
Sep 29, 2022
Femasys Inc. Announces the Commercial Availability of FemCerv® for Cervical Cancer Screening and Expands Management Team
GlobeNewswire
Read ↗
Sep 8, 2022
Tech Companies Working On Contraception Face A New Landscape After Roe
Buzzfeed News
Read ↗
Aug 30, 2022
Femasys innovating women’s reproductive health with minimally invasive, in-office technologies
BioTuesdays
Read ↗
Aug 1, 2022
How Diversity And Motherhood Fortified Me As A Women’s Health CEO
Life Science Leader
Read ↗
Stay Current
Women’s health news, delivered.
Get the latest Femasys updates — from progress on FemaSeed® fertility commercialization and the FemBloc® U.S. clinical trial to educational events and press releases — delivered directly to your inbox.
You can unsubscribe from these communications at any time.
For more information on our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.